Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias

Nature Reviews Genetics

Volumn 2, Issue 4, 2001, Pages 245-255

  Weatherall, D J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; HEMOGLOBIN; IRON;

ALLELE; BIOSYNTHESIS; BONE DISEASE; DOMINANT GENE; ENVIRONMENT; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; METABOLISM; MULTIGENE FAMILY; MUTATION; PHENOTYPE; RECESSIVE GENE; REVIEW; THALASSEMIA;

ALLELES; BILIRUBIN; BONE DISEASES; ENVIRONMENT; GENES, DOMINANT; GENES, RECESSIVE; GENOTYPE; HEMOGLOBINS; HUMANS; IRON; MULTIGENE FAMILY; MUTATION; PHENOTYPE; THALASSEMIA; VARIATION (GENETICS);

EID: 0035320886     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/35066048     Document Type: Review

References (81)

1. Weatherall, D. J. & Clegg, J. B. The Thalassaemia Syndromes 4th edn (Blackwell Science, Oxford, 2001). The principal monograph on thalassaemia: the fourth edition covers every aspect of the field and contains over 3,000 references.
2. Weatherall, D. J. & Clegg, J. B. Thalassaemia - a global public health problem. Nature Med. 2, 847-849 (1996).
3. Weatherall, D. J., Clegg, J. B., Higgs, D. R. & Wood, W. G. in The Metabolic and Molecular Bases of Inherited Disease (ed. Scriver, C. R.) 4571-4636 (McGraw-Hill, New York, 2001).
4. Stamatoyannopoulos, G. & Grosveld, F. in The Molecular Basis of Blood Disease (eds Stamatoyannopoulos, G., Majerus, P. W., Perimutter, R. M. & Varmus, H.) 135-182 (Saunders, New York, 2001). An excellent up-to-date review on what is known about the mechanisms of the differential expression of the globin genes during development.
5. World Health Organization. Guidelines for the control of haemoglobin disorders. Report of the VIth Annual Meeting of the WHO Working Group on Haemoglobinopathies, Cagliari, Sardinia, 8-9 April, 1989 (1994).
6. Huisman, T. H. J., Carver, M. F. H. & Efremov, G. D. A Syllabus of Human Hemoglobin Variants (Sickle Cell Foundation, Augusta, Georgia, 1998).
7. Higgs, D. R. in Baillière's Clinical Haematology. International Practice and Research: The Haemoglobinopathies (eds Higgs, D. R. & Weatherall, D. J.) 117-150 (Baillière Tindall, London, 1993).
8. ε-globin gene. Nature 300, 768-769 (1982).
9. Weatherall, D. J. Pathophysiology of thalassaemia. Clin. Haematol. 11, 127-146 (1998).
10. Weatherall, D. J. et al. A genetically determined disorder with features both of thalassaemia and congenital dyserythropoietic anaemia. Br. J. Haematol. 24, 681-702 (1973).
11. Stamatoyannopoulos, G., Woodson, R., Papayannopoulou, T., Heywood, D. & Kurachi, M. S. Inclusion-body β-thalassemia trait. A form of β thalassemia producing clinical manifestations in simple heterozygotes. N. Engl. J. Med. 290, 939-943 (1974).
12. Wainscoat, J. S., Thein, S. L. & Weatherall, D. J. Thalassaemia intermedia. Blood Rev. 1, 273-279 (1987).
13. Fiorelli, G., Sampietro, M., Romano, M., Albano, M. & Cappellini, M. D. Clinical features of thalassemia intermedia in Italy. Birth Defects: Original Articles Ser. 23, 287-295 (1988).
14. Cao, A., Gasperini, D., Podda, A. & Galanello, R. Molecular pathology of thalassemia intermedia. Eur. J. Int. Med. 1, 227-236 (1990).
15. Rund, D. et al. Genetic analysis of β-thalassemia intermedia in Israel: diversity of mechanisms and unpredictability of phenotype. Am. J. Hematol. 54, 16-22 (1997).
16. Ho, P. J., Hall, G. W., Luo, L. Y., Weatherall, D. J. & Thein, S. L. β thalassaemia intermedia: is it possible to predict phenotype from genotype? Br. J. Haematol. 100, 70-78 (1998). The most complete analysis so far of the molecular mechanisms for the milder forms of β-thalassaemia.
17. Huisman, T. H. J., Carver, M. F. H. & Baysal, E. A Syllabus of Thalassemia Mutations 1-309 (The Sickle Cell Anemia Foundation, Augusta, Georgia, 1997). A complete and detailed catalogue of all the published thalassaemia mutations and their geographical distribution up to 1997.
18. Schwartz, E. The silent carrier of β thalassemia. N. Engl. J. Med. 281, 1327-1333 (1969).
19. Gonzalez-Redondo, J. H. et al. A CØT substitution at nt-101 in a conserved DNA sequence of the promoter region of the β-globin gene is associated with 'silent' β-thalassemia. Blood 73, 1705-1711 (1989).
20. Bianco, I. et al. Silent thalassemias: genotypes and phenotypes. Haematologica 82, 269-280 (1997).
21. Gonzalez-Redondo, J. H. et al. Clinical and genetic heterogeneity in black patients with homozygous β-thalassemia from the Southeastern United States. Blood 72, 1007-1014 (1988).
22. ○ thalassaemia -Portuguese type: clinical, haematological and molecular studies of a newly defined form of β thalassaemia. Br. J. Haematol. 54, 189-200 (1983).
23. Efremov, D. et al. Possible factors influencing the haemoglobin and fetal haemoglobin levels in patients with β-thalassaemia due to a homozygosity for the IVS-1-6 (T-C) mutation. Br. J. Haematol. 86, 824-830 (1994).
24. Thein, S. L. et al. Molecular basis for dominantly inherited inclusion body β thalassemia. Proc. Natl Acad. Sci. USA 87, 3924-3928 (1990).
25. Ho, P. J. et al. Erythroblastic inclusions in dominantly inherited β thalassaemias. Blood 89, 322-328 (1997).
26. Kazazian, H. H., Dowling, C. E., Hurwitz, R. L., Coleman, M. & Adams, J. G. I. Thalassemia mutations in exon 3 of the β-globin gene often cause a dominant form of thalassemia and show no predilection for malarial-endemic regions of the world. Am. J. Hum. Genet 45, A242 (1989).
27. Thein, S.L. Dominant β thalassaemia: molecular basis and pathophysiology. Br. J. Haematol. 80, 273-277 (1992).
28. Thein, S. L. Is it dominantly inherited β thalassaemia or just a β-chain variant that is highly unstable? Br. J. Haematol. 107, 12-21 (1999). An extensive review of the pathophysiology of the dominant β-thalassaemias.
29. Sachs, A. B. Messenger RNA degradaton in eukaryotes. Cell 74, 413-421 (1993).
30. Thermann, R. et al. Binary specification of nonsense codons by splicing and cytoplasmic translation. EMBO J. 17, 3484-3494 (1998).
31. Zhang, J., Sun, X., Qian, Y. & Maquat, L. E. Intron function in the nonsense-mediated decay of β-globin mRNA: indications that pre-mRNA splicing in the nucleus can influence mRNA translation in the cytoplasm. RNA 4, 801-815 (1998).
32. ○-thalassemia intermedia. Blood 52, 345-349 (1978).
33. Weatherall, D. J. et al. The clinical and molecular heterogeneity of the thalassaemia syndromes. Ann. NY Acad. Sci. 344, 83-100 (1980).
34. Rees, D. C., Styles, J., Vichinsky, E. P., Clegg, J. B. & Weatherall, D. J. The hemoglobin E syndromes. Ann. NY Acad. Sci. 850, 334-343 (1998).
35. De Silva, S. et al. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Lancet 355, 786-791 (2000).
36. Kan, Y. W. & Nathan, D. G. Mild thalassemia: the result of interactions of α and β thalassemia genes. J. Clin. Invest. 49, 635-642 (1970).
37. ○-thalassemia intermedia in Sardinia. Blood 74, 823-827 (1989).
38. Weatherall, D. J., Pressley, L, Wood, W. G., Higgs, D. R. & Clegg, J. B. The molecular basis for mild forms of homozygous β thalassaemia. Lancet 1, 527-529 (1981).
39. Knox-Macaulay, H. H. M., Weatherall, D. J., Clegg, J. B., Bradley, J. & Brown, M. J. Clinical and biosynthetic characterization of αβ-thalassaemia. Br. J. Haematol. 22, 497-512 (1972).
40. Boyer, S. H., Belding, T. K., Margolet, L. & Noyes, A. N. Fetal hemoglobin restriction to a few erythrocytes (F cells) in normal human adults. Science 188, 361-363 (1975).
41. Rees, D. C., Porter, J. B., Clegg, J. B. & Weatherall, D. J. Why are hemoglobin F levels increased in Hb E/β thalassemia? Blood 94, 3199-3204 (1999).
42. Garner, C. et al. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 95, 342-346 (2000). The most extensive study so far on the genetic factors that modify the small amounts of fetal haemaglobin that are produced In normal adults.
43. γ globin production. Blood 66, 783-787 (1985).
44. γ-globin gene expression and high Hb F levels in β-thalassemia and sickle cell anemia patients. Proc. Natl Acad. Sci. USA 82, 2111-2114 (1965).
45. Thein, S. L. et al. Association of thalassaemia intermedia with a β-globin gene haplotype. Br. J. Haematol. 65, 370-373 (1987).
46. Thein, S. L in Baillière's Clinical Haematology. International Practice and Research: The Haemoglobinopathies (eds Higgs, D. R. & Weatherall, D. J.) 151-176 (Baillière Tindall, London, 1993).
47. Thein, S. L. & Weatherall, D. J. in Hemoglobin Switching. B. Cellular and Molecular Mechanisms (eds Stamatoyannopoulos, G. & Nienhuis, A. W.) 97-112 (Alan R. Liss, New York, 1989).
48. Craig, J. E. et al. Haemoglobin switch: dissecting the loci controlling fetal haemoglobin production on chromosomes 11 p and 6q by the regressive approach. Nature Genet. 12, 58-64 (1996). A model approach to dissecting the loci that modify fetal haemaglobin production in the haemoglobin disorders.
49. Craig, J. E. et al. Genetic heterogeneity in heterocellular hereditary persistence of fetal hemoglobin. Blood 90, 428-434 (1997).
50. Dover, G. J. et al. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood 80, 816-824 (1992).
51. Higgs, D. R., Old, J. M., Pressley, L. Clegg, J. B. & Weatherall, D. J. A novel α-globin gene arrangement in man. Nature 284, 632-635 (1980).
52. Goossens, M. et al. Triplicated α-globin loci in humans'. Proc. Natl Acad. Sci. USA 77, 518-521 (1980).
53. Kanavakis, E., Metaxatou-Mavromati, A., Kattamis, C., Wainscoat, J. S. & Wood, W. G. The triplicated α gene locus and β thalassaemia. Br. J. Haematol. 54, 201-207 (1983).
54. Galanello, R. et al. A family with segregating triplicated α globin loci and β thalassemia. Blood 62, 1035-1040 (1983).
55. Thompson, C. C., Ali, M. A. & Vacovsky, M. The interaction of anti 3.7 type quadruplicated α-globin genes and heterozygous β-thalassemia. Hemoglobin 13, 125-135 (1989).
56. ○-thalassaemia and quadruplicated α-globin gene arrangement of the anti-4.2 type. Br. J. Haematol. 105, 1074-1080 (1999).
57. Galanello, R. et al. Hyperbilirubinaemia in heterozygous β-thalassaemia is related to co-inherited Gilbert's syndrome. Br. J. Haematol. 99, 433-436 (1997).
58. Sampietro, M. et al. The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous β-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency. Br. J. Haematol. 99, 437-439 (1997).
59. Rees, D. C., Singh, B. M., Luo, L. Y., Wickramasinghe, S. & Thein, S. L. Nontransfusional iron overload in thalassemia: association with hereditary hemochromatosis. Ann. NY Acad. Sci. 850, 490-494 (1998).
60. Piperno, A. et al. Haemochromatosis in patients with β-thalassaemia trait Br. J. Haematol. 111, 908-914 (2000).
61. Merryweather-Clarke, A. T., Pointon, J. J., Shearman, J. D. & Robson, K. J. H. Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 34, 275-278 (1997).
62. Andrews, N. C. Iron homeostasis: insights from genetics and animal models. Nature Rev. Genet. 1, 208-217 (2000). An extensive review of new insights into iron homeostasis that discusses the many gene candidates for modifiers of iron loading.
63. Rees, D. C. et al. Genetic influences on bone disease in thalassemia. Blood 92, S532a (1998).
64. Wonke, B. Annotation: bone disease in β-thalassaemia major. Br. J. Haematol. 103, 897-901 (1998). An up-to-date outline of the acquired and potential genetic factors that might modify osteoporosis in β-thalassaemia.
65. Perrota, S. et al. Osteoporosis in β thalassaemia major patients: analysis of the genetic background. Br. J. Haematol. 111, 461-456 (2000).
66. Dresner Pollak, R., Rachmilewitz, E., Blumenfeld, A., Idelson, M. & Goldfarb, A. W. Bone mineral metabolism in adults with β-thalassaemia major and intermedia. Br. J. Haematol. 111, 902-907 (2000).
67. Williams, T. N. et al. High incidence of malaria in α-thalassaemic children. Nature 383, 522-525 (1996).
68. +-thalassaemia protects children against disease due to malaria and other infections. Proc. Natl Acad. Sci. USA 94, 14736-14741 (1997).
69. Weatherall, D. J., Clegg, J. B. & Kwiatkowski, D. The role of genomics in studying genetic susceptibility to infectious disease. Genome Res. 7, 967-973 (1997). An extensive review of the malaria-related genetic polymorphisms and polymorphisms that alter susceptibility to other infectious agents.
70. Hill, A. V. S., Allsopp, C. E. M. & Kwiatkowski, D. Common west African HLA antigens are associated with protection from severe malaria. Nature 352, 595-600 (1991).
71. McGuire, W., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M. & Kwiatkowski, D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371, 500-511 (1994).
72. Fernandez-Reyes, D. et al. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum. Mol. Genet. 6, 1357-1360 (1997).
73. Weatherall, D. J. Thalassemia in the next millennium. Ann. NY Acad. Sci. 850, 1-9 (1998).
74. Fouladi, M. et al. Hemoglobin E/β thalassemia: the Canadian experience. Ann. NY Acad. Sci. 850, 410-411 (1998).
75. Rees, D. C., Clegg, J. B. & Weatherall, D. J. Is hemoglobin instability important in the interaction between hemoglobin E and β thalassemia? Blood 92, 2141-2146 (1998).
76. Chinprasertsuk, S., Wanachiwanawin, W. & Piankijagum, A. Effect of pyrexia in the formation of intraerythrocytic inclusion bodies and vacuoles in haemolytic crisis of haemoglobin H disease. Eur. J. Haematol. 52, 87-91 (1994).
77. Weatherall, D. J. From genotype to phenotype: genetics and medical practice in the new millennium. Phil. Trans. R. Soc. Lond. B 354, 1995-2010 (1999). An extensive review of phenotype-genotype relationships in monogenic disease, including those other than the haemoglobin disorders.
78. Summers, K. M. Relationship between genotype and phenotype in monogenic diseases: relevance to polygenic diseases. Hum. Mutat. 7, 283-293 (1996).
79. Wolf, U. Identical mutations and phenotypic variation. Hum. Genet. 100, 305-321 (1997). A valuable review of the phenotype-genotype relationships for monogenic disease.
80. Bunn, H. F. Pathogenesis and treatment of sickle cell disease. N. Engl. J. Med. 337, 762-769 (1997).
81. Weatherall, D. J. Gene therapy: repairing haemoglobin disorders with ribozymes. Curr. Biol. 8, R696-R698 (1998).